Abstract
P-glycoprotein (P-gp) is a drug efflux transporter with broad substrate specificity localized in the blood-brain barrier and in several peripheral organs. In order to understand the role of P-gp in physiological and patho-physiological conditions, several carbon-11 labelled P-gp tracers have been developed and validated. This review provides an overview of the spectrum of radiopharmaceuticals that is available for this purpose. A short overview of the physiology of the blood-brain barrier in health and disease is also provided. Tracer kinetic modelling for quantitative analysis of P-gp function and expression is highlighted, and the advantages and disadvantages of the various tracers are discussed.
Keywords: PET, P-glycoprotein, blood-brain barrier, radiopharmaceuticals, tracer-kinetic modeling, Carbon-11 Labeled Tracers, P-Glycoprotein Function, P-gp tracers, Alzheimer's disease, Epilepsy, Parkinson's disease, Multidrug resistance-associated proteins (MRP), Substrates, Inhibitors, Nucleotide-binding domains (NBDs), ATP hydrolysis, Modulators, Constant of dissociation (Kd), β-amyloid peptide (Aβ), Radiolabeling, cytochrome P450 (cyp 450), [11C]verapamil, [11C]colchicine, [11C]daunorubicin, [11C]loperamide, [11C]/[18F]paclitaxel, [11C]Docetaxel, [11C]D617, [11C]Carvedilol, [11C]Laniquidar, [11C]Elacridar, [11C]MC18, [11C]Tariquidar
Current Topics in Medicinal Chemistry
Title: Carbon-11 Labeled Tracers for In Vivo Imaging of P-Glycoprotein Function: Kinetics, Advantages and Disadvantages
Volume: 10 Issue: 17
Author(s): Gert Luurtsema, Joost Verbeek, Mark Lubberink, Adriaan A. Lammertsma, Rudi Dierckx, Philip Elsinga, Albert D. Windhorst and Aren van Waarde
Affiliation:
Keywords: PET, P-glycoprotein, blood-brain barrier, radiopharmaceuticals, tracer-kinetic modeling, Carbon-11 Labeled Tracers, P-Glycoprotein Function, P-gp tracers, Alzheimer's disease, Epilepsy, Parkinson's disease, Multidrug resistance-associated proteins (MRP), Substrates, Inhibitors, Nucleotide-binding domains (NBDs), ATP hydrolysis, Modulators, Constant of dissociation (Kd), β-amyloid peptide (Aβ), Radiolabeling, cytochrome P450 (cyp 450), [11C]verapamil, [11C]colchicine, [11C]daunorubicin, [11C]loperamide, [11C]/[18F]paclitaxel, [11C]Docetaxel, [11C]D617, [11C]Carvedilol, [11C]Laniquidar, [11C]Elacridar, [11C]MC18, [11C]Tariquidar
Abstract: P-glycoprotein (P-gp) is a drug efflux transporter with broad substrate specificity localized in the blood-brain barrier and in several peripheral organs. In order to understand the role of P-gp in physiological and patho-physiological conditions, several carbon-11 labelled P-gp tracers have been developed and validated. This review provides an overview of the spectrum of radiopharmaceuticals that is available for this purpose. A short overview of the physiology of the blood-brain barrier in health and disease is also provided. Tracer kinetic modelling for quantitative analysis of P-gp function and expression is highlighted, and the advantages and disadvantages of the various tracers are discussed.
Export Options
About this article
Cite this article as:
Luurtsema Gert, Verbeek Joost, Lubberink Mark, A. Lammertsma Adriaan, Dierckx Rudi, Elsinga Philip, D. Windhorst Albert and van Waarde Aren, Carbon-11 Labeled Tracers for In Vivo Imaging of P-Glycoprotein Function: Kinetics, Advantages and Disadvantages, Current Topics in Medicinal Chemistry 2010; 10 (17) . https://dx.doi.org/10.2174/156802610792928013
DOI https://dx.doi.org/10.2174/156802610792928013 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Medicinal Chemistry Advancement in Life-Threatening Diseases
The current issue will highlight concise reports that specify ground-breaking insights, including the novel discovery of drug targets and their action mechanism or drugs of novel classes. These are projected to encourage medicinal chemistry future efforts to address the most challenging medical needs. The current issue highlights further efforts to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Adenosine and ATP Receptors in the Brain
Current Topics in Medicinal Chemistry Voltage-Gated Sodium Channels in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Biotransformation of Microcystins in Eukaryotic Cells - Possible Future Research Directions
Mini-Reviews in Medicinal Chemistry Diagnostic Imaging of Fetal and Neonatal Abdominal and Soft Tissue Tumors
Current Pediatric Reviews Organosulphur Compounds Induce Apoptosis and Cell Cycle Arrest in Cervical Cancer Cells via Downregulation of HPV E6 and E7 Oncogenes
Anti-Cancer Agents in Medicinal Chemistry Copper and Heme-Mediated Abeta Toxicity: Redox Chemistry, Abeta Oxidations and Anti-ROS Compounds
Current Topics in Medicinal Chemistry Natural Thiazoline-Based Cyclodepsipeptides from Marine Cyanobacteria: Chemistry, Bioefficiency and Clinical Aspects
Current Medicinal Chemistry Patents in Cancer Stem Cells
Recent Patents on Biomarkers Metabolism and the Paradoxical Effects of Arsenic: Carcinogenesis and Anticancer
Current Medicinal Chemistry Genetic Surgery - A Right Strategy to Attack Cancer
Current Gene Therapy Insulin-Degrading Enzyme: Structure-Function Relationship and its Possible Roles in Health and Disease
Current Pharmaceutical Design Long non-coding RNAs in Alzheimer’s disease
Current Topics in Medicinal Chemistry Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Potential Interactions between miRNAs and Hypoxia: A New Layer in Cancer Hypoxia
Anti-Cancer Agents in Medicinal Chemistry Phytochemicals: Potential in Management of Climacteric Neurobiology
Current Pharmaceutical Design Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection
Current Stem Cell Research & Therapy miRNAs as Modulators of Cholesterol in Breast Cancer Stem Cells: An Approach to Overcome Drug Resistance in Cancer
Current Drug Targets Emerging Potential of Naturally Occurring Autophagy Modulators Against Neurodegeneration
Current Pharmaceutical Design Editorial (A Significant Step Towards New Altitude)
Current Molecular Medicine Promises of Apoptosis-Inducing Peptides in Cancer Therapeutics
Current Pharmaceutical Biotechnology